Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 41INDUSTRY 4NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 115Rectal Neoplasms 77Colonic Neoplasms 71Pancreatic Neoplasms 38Stomach Neoplasms 34Esophageal Neoplasms 29Anus Neoplasms 18Adenocarcinoma Of Esophagus 17Carcinoma, Non-Small-Cell Lung 14Carcinoma, Hepatocellular 14Breast Neoplasms 14Biliary Tract Neoplasms 14Neoplasm Metastasis 11Liver Neoplasms 11Lung Neoplasms 10Sarcoma 9Hepatoblastoma 9Gastrointestinal Stromal Tumors 9Ovarian Neoplasms 8Neoplasms 8HIV Infections 8Prostatic Neoplasms 7Gallbladder Neoplasms 7Esophageal Squamous Cell Carcinoma 7Anal Canal Carcinoma 7Small Cell Lung Carcinoma 6Precancerous Conditions 6Neuroblastoma 6Uterine Cervical Neoplasms 5Osteosarcoma 5

Interventions

dehydroftorafur 1Taxes 1Pancreatectomy 1Oxaliplatin 1Irinotecan 1Gemcitabine 1Fluorouracil 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Pancreatic Adenocarcinoma × Gastrointestinal × Clear all
NCT02562716 2022-10-19

S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
147 enrolled 16 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡